BackgroundCheck.run
Search For

Scott I Hauenstein, 453643 Caminito Carmel Lndg, San Diego, CA 92130

Known as:
Scott Ian Hauenstein Scott Hausenstein Scotti Hauenstein Scott Havenstein Scott M Hauenstein Scotti
Related to:
Rebecca I Hauenstein

Scott Hauenstein Phones & Addresses

3643 Caminito Carmel Lndg, San Diego, CA 92130   

3565 Caminito El Rincon, San Diego, CA 92130    858-4610543   

12283 Carmel Vista Rd, San Diego, CA 92130    858-4610543   

Ventura, CA   

6736 Trigo Rd, Goleta, CA 93117   

Santa Barbara, CA   

Portland, OR   

Samoa, CA   

Get Report
Control this profile

Mentions for Scott I Hauenstein

Scott Hauenstein resumes & CV records

Resumes

Scott Hauenstein Photo 15

Technical Support Specialist

Location:
7412 south Lancaster Rd, Dallas, TX 75241
Industry:
Consumer Services
Work:
The Howard Company
Technical Support Specialist Soredex Dec 2014 - Mar 2015
Technical Support Representative Direct Supply Aug 2014 - Dec 2014
Service Desk Specialist Direct Supply Aug 2013 - Aug 2014
Local Services Associate Ari Network Services, Inc. Aug 1999 - May 2013
Dealer and Oem Technical Support Representative Bmo Harris Bank Sep 1996 - May 1999
Consumer Loan Specialist and Technical Support Specialist Target Nov 1992 - Aug 1996
Hardlines Specialist
Education:
Central High School 1988 - 1992
Skills:
Technical Support, Troubleshooting, Customer Service, Software Documentation, Salesforce.com, Team Leadership, Training, Html, Software Installation, Hardware, Microsoft Office, E Commerce, Windows 7, Windows, Management, Computer Hardware, Software Quality Assurance, Hands on Training, Webex, Help Desk Support, Access, Microsoft Excel, Microsoft Word, Team Building, Ios, Spice, Web Content Management, Computers, Logmein, Gimp, Android
Interests:
Writing
Japanese Language
Multimedia and Computer Innovations
Social Media
Pc Gaming
Reading
Japanese Historical and Modern Study
Customer Service
Scott Hauenstein Photo 16

Senior Manager Scientific Affairs, Molecular Diagnostics

Location:
San Diego, CA
Industry:
Biotechnology
Work:
Bio-Rad Laboratories
Senior Manager Scientific Affairs, Molecular Diagnostics Hologic, Inc. Jul 2014 - Nov 2018
Senior Manager, Scientific Affairs Virology Prometheus Laboratories Inc., A Nestlé Health Science Company Sep 2010 - Jun 2014
Associate Director, Research and Development Sirna Consulting Llc Dec 2009 - Sep 2010
Partner Chimeros Nov 2007 - Sep 2009
Scientist I Cal State Channel Islands 2006 - 2007
Lecturer
Education:
Uc Santa Barbara 2002 - 2007
Doctorates, Doctor of Philosophy, Biochemistry, Chemistry Uc Santa Barbara 1998 - 2002
Bachelors, Bachelor of Science, Biochemistry
Skills:
Assay Development, Biochemistry, Protein Chemistry, Immunology, Qpcr, Protein Purification, Hplc, Elisa, Public Speaking, Structural Biology, Enzyme Assays, Project Management, Management, Western Blotting, Chromatography, Problem Solving, Diagnostic, Team Leadership, Presentations, Databases
Scott Hauenstein Photo 17

Scott Hauenstein

Publications & IP owners

Us Patents

Methods For Determining Anti-Drug Antibody Isotypes

US Patent:
2013034, Dec 26, 2013
Filed:
Apr 17, 2013
Appl. No.:
13/865139
Inventors:
Linda Ohrmund - San Diego CA, US
Scott Hauenstein - San Diego CA, US
Sharat Singh - Rancho Santa Fe CA, US
International Classification:
G01N 33/68
US Classification:
436501
Abstract:
The present invention provides assay methods for the determination of one or more anti-drug antibody (ADA) isotypes in a sample. As a non-limiting example, the assays of the present invention are particularly useful for determining different ADA isotypes in samples from ADA-positive patients receiving an anti-TNFα drug such as REMICADE™ (infliximab) or HUMIRA™ (adalimumab). The present invention also provides methods for optimizing therapy and/or reducing toxicity in subjects receiving TNFα inhibitors for the treatment of TNFα-mediated disease or disorders.

Assays For Detecting Autoantibodies To Anti-Tnfalpha Drugs

US Patent:
2014004, Feb 13, 2014
Filed:
Aug 7, 2013
Appl. No.:
13/961841
Inventors:
- Vevey, CH
Shui Long Wang - San Diego CA, US
Linda Ohrmund - San Diego CA, US
Scott Hauenstein - San Diego CA, US
International Classification:
G01N 33/564
US Classification:
436501
Abstract:
The present invention provides assays for detecting and measuring the presence or level of autoantibodies to anti-TNFα drug therapeutics in a sample. The present invention is useful for optimizing therapy and monitoring patients receiving anti-TNFα drug therapeutics to detect the presence or level of autoantibodies against the drug. The present invention also provides methods for selecting therapy, optimizing therapy, and/or reducing toxicity in subjects receiving anti-TNFα drugs for the treatment of TNFα-mediated disease or disorders.

Mobility Shift Assays For Detecting Anti-Tnf Alpha Drugs And Autoantibodies Thereto

US Patent:
2014005, Feb 20, 2014
Filed:
Mar 12, 2013
Appl. No.:
13/797815
Inventors:
- Vevey, CH
Scott Hauenstein - San Diego CA, US
Linda Ohrmund - San Diego CA, US
International Classification:
G01N 33/537
US Classification:
436501
Abstract:
The present invention provides assays for detecting and measuring the presence or level anti-TNFα drugs and/or the autoantibodies to anti-TNFα drugs in a sample. The present invention is useful for optimizing therapy and monitoring patients receiving anti-TNFα drug therapeutics to detect the presence or level of autoantibodies against the drug. The present invention also provides methods for selecting therapy, optimizing therapy, and/or reducing toxicity in subjects receiving anti-TNFα drugs for the treatment of TNFα-mediated disease or disorders.

Mobility Shift Assays For Detecting Anti-Tnf Alpha Drugs And Autoantibodies

US Patent:
2013029, Nov 7, 2013
Filed:
Apr 9, 2013
Appl. No.:
13/859664
Inventors:
Scott Hauenstein - San diego CA, US
Linda Ohrmund - San Diego CA, US
International Classification:
G01N 33/537
US Classification:
436501
Abstract:
The present invention provides assays for detecting and measuring the presence or level of anti-TNFα drugs and/or the autoantibodies to anti-TNFα drugs in a sample. The present invention is useful for optimizing therapy and monitoring patients receiving anti-TNFα drug therapeutics to detect the presence or level of autoantibodies against the drug. The present invention also provides methods for selecting therapy, optimizing therapy, and/or reducing toxicity in subjects receiving anti-TNFα drugs for the treatment of TNFα-mediated disease or disorders.

Methods Of Disease Activity Profiling For Personalized Therapy Management

US Patent:
2019006, Feb 28, 2019
Filed:
Aug 24, 2018
Appl. No.:
16/112242
Inventors:
- Vevey, CH
Nicholas Hoe - San Diego CA, US
Steve Lockton - San Diego CA, US
Scott Hauenstein - San Diego CA, US
Linda Ohrmund - San Diego CA, US
Assignee:
Nestec S.A. - Vevey
International Classification:
A61K 39/395
G01N 33/68
C12Q 1/6883
Abstract:
The present invention provides methods for personalized therapeutic management of a disease in order to optimize therapy and/or monitor therapeutic efficacy. In particular, the present invention comprises measuring an array of one or a plurality of biomarkers at a plurality of time points over the course of therapy with a therapeutic agent to determine a mucosal healing index for selecting therapy, optimizing therapy, reducing toxicity, and/or monitoring the efficacy of therapeutic treatment. In certain instances, the therapeutic agent is a TNFα inhibitor for the treatment of a TNFα-mediated disease or disorder.

Methods For Predicting And Monitoring Mucosal Healing

US Patent:
2015035, Dec 10, 2015
Filed:
Apr 3, 2015
Appl. No.:
14/678455
Inventors:
- Vevey, CH
Xinjun Liu - San Diego CA, US
Scott Hauenstein - San Diego CA, US
Richard Kirkland - San Diego CA, US
Katherine Drake - San Diego CA, US
Assignee:
NESTEC S.A. - Vevey
International Classification:
G01N 33/68
G06F 19/00
Abstract:
The present invention provides methods for predicting the likelihood of mucosal healing in an individual with a disease such as inflammatory bowel disease (IBD). In addition, the present invention provides methods for monitoring the progression of mucosal healing in an individual with a disease such as IBD. Information on mucosal healing status derived from the use of the present invention can also aid in optimizing therapy and/or monitoring the therapeutic efficiency of an anti-TNFα inhibitor drug.

Methods Of Disease Activity Profiling For Personalized Therapy Management

US Patent:
2014014, May 22, 2014
Filed:
Nov 5, 2013
Appl. No.:
14/072746
Inventors:
- Vevey, CH
Nicholas Hoe - San Diego CA, US
Steve Lockton - San Diego CA, US
Scott Hauenstein - San Diego CA, US
Linda Ohrmund - San Diego CA, US
Assignee:
NESTEC S.A. - Vevey
International Classification:
A61K 39/395
US Classification:
506 7
Abstract:
The present invention provides methods for personalized therapeutic management of a disease in order to optimize therapy and/or monitor therapeutic efficacy. In particular, the present invention comprises measuring an array of one or a plurality of biomarkers at a plurality of time points over the course of therapy with a therapeutic agent to determine a mucosal healing index for selecting therapy, optimizing therapy, reducing toxicity, and/or monitoring the efficacy of therapeutic treatment. In certain instances, the therapeutic agent is a TNFα inhibitor for the treatment of a TNFα-mediated disease or disorder.

Possible Relatives

David G Hauenstein  Dennis B Hauenstein  Gary E Hauenstein  George Hauenstein  Jack W Hauenstein  James G Hauenstein  John D Hauenstein  Scott D Johnson  Scott A Stanard  Scott B Standley 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.